Maternal Deltamethrin Exposure Drives p53-Dependent Ferroptosis and Cognitive Deficits in Offspring

Study Background and Research Question

Deltamethrin (DM) is a widely used type II pyrethroid insecticide, notable for its environmental persistence and neurotoxic potential. Human and animal exposure to DM primarily occurs through contaminated food and water, raising public health concerns due to its ability to cross the blood-brain barrier and disrupt neural function. Epidemiological and experimental evidence suggests that DM exposure during critical developmental windows may cause persistent neurobehavioral alterations, particularly affecting learning and memory. However, the precise molecular mechanisms underlying these neurodevelopmental effects have remained unclear.

The referenced study (Huang et al., 2025) addresses a critical gap by investigating whether maternal DM exposure during gestation and lactation impairs hippocampal-dependent learning and memory in male offspring via ferroptosis—a regulated form of cell death characterized by iron-dependent lipid peroxidation—and explores the involvement of the p53 signaling pathway in this process.

Key Innovation from the Reference Study

The central innovation of this research lies in the comprehensive demonstration that p53-mediated ferroptosis is a primary driver of hippocampal dysfunction following maternal DM exposure. Not only does the study show behavioral deficits and neuronal loss in the offspring, but it also elucidates a mechanistic cascade from DM-induced oxidative stress and iron overload to activation of the p53/SLC7A11/GPX4 axis, culminating in ferroptosis. The use of both in vivo (rat model) and in vitro (HT-22 hippocampal cells) systems, coupled with pharmacological inhibition of ferroptosis and p53, provides robust evidence for this pathway.

Methods and Experimental Design Insights

Prenatal and early postnatal exposure was modeled by orally administering DM to pregnant Wistar rats at doses of 0, 1, 4, or 10 mg/kg/day from gestational day 0 to postnatal day 21. Male offspring were subsequently assessed using behavioral paradigms sensitive to hippocampal function, including T-maze tests for spatial working memory and shuttle box tasks for avoidance learning. Histological analysis via Nissl staining quantified hippocampal neuronal survival.

To dissect cellular and molecular mechanisms, hippocampal tissue was analyzed for markers of ferroptosis (ferrous ion, malondialdehyde [MDA], PTGS2 protein) and antioxidant status (glutathione [GSH] levels). The signaling cascade involving phospholipase C (PL-C), inositol triphosphate receptor (IP3R), intracellular Ca²⁺, and calcineurin (CaN) was also assessed, given its relevance to calcium homeostasis.

In vitro, the HT-22 neuronal cell line was exposed to DM with or without intervention using ferrostatin-1 (a ferroptosis inhibitor) and Pifithrin-α (a p53 inhibitor), allowing direct evaluation of the contributions of ferroptosis and p53 activity to DM-induced cytotoxicity.

Protocol Parameters

• Maternal DM exposure: 0, 1, 4, or 10 mg/kg/day via gavage from gestational day 0 to postnatal day 21 for in vivo models.
• Behavioral testing: T-maze correctness and shuttle box passive avoidance rate measured in male offspring post-exposure.
• Histological analysis: Nissl staining performed on hippocampal slices to quantify neuron survival.
• Biochemical assays: Quantification of ferrous ion, MDA, PTGS2, and GSH in hippocampal tissue.
• In vitro modulation: HT-22 cells treated with DM, with/without ferrostatin-1 or Pifithrin-α to dissect pathway contributions.

Core Findings and Why They Matter

Maternal DM exposure significantly impaired offspring learning and memory, evidenced by reduced T-maze correctness and increased passive avoidance, alongside neuronal loss in the hippocampus (Huang et al., 2025). At the molecular level, DM exposure elevated hippocampal ferrous ion and MDA, increased PTGS2 expression, and depleted GSH, fulfilling criteria for ferroptosis. Importantly, the study mapped this ferroptotic response to the p53/SLC7A11/GPX4 axis: p53 activation suppressed SLC7A11 and GPX4, key regulators of glutathione-dependent lipid repair and ferroptosis resistance.

Downstream, the resulting ferroptosis activated the PL-C/IP3R pathway, elevating intracellular Ca²⁺ and CaN, thus disrupting calcium homeostasis—a critical event in neurotoxicity and cognitive dysfunction. In vitro, both ferrostatin-1 and Pifithrin-α interventions protected HT-22 cells from DM-induced ferroptosis, confirming the centrality of p53 in this process.

These findings underscore the vulnerability of the developing brain to environmental toxicants through p53-dependent apoptosis inhibition and ferroptosis, highlighting potential translational targets for neuroprotection.

Comparison with Existing Internal Articles

The mechanistic focus of the present study directly complements prior syntheses of p53 pathway inhibitors in neuroprotection and ferroptosis research. For instance, "Pifithrin-α (PFTα): Precision p53 Inhibition for Advanced Neuroprotection" and "Strategic p53 Modulation with Pifithrin-α (PFTα)" both discuss the utility of Pifithrin-α as a p53 inhibitor for dissecting the role of p53 in cell death, including ferroptosis and apoptosis, with implications for both neurodevelopmental and cancer models.

Unlike earlier reviews that emphasize protocol optimization and broader translational opportunities for Pifithrin-α, this study provides direct in vivo and in vitro evidence linking maternal environmental neurotoxicant exposure to p53-mediated ferroptosis and cognitive impairment. This positions the reference work as a crucial addition to the literature, validating the relevance of p53 inhibitors in mitigating environmental neurotoxicity and extending the evidence base for targeted intervention strategies.

Limitations and Transferability

While the study employs rigorous experimental controls and multimodal assessment, several limitations merit consideration. The focus on male offspring aligns with previous findings of sex-dependent neurotoxicity but limits generalizability to females. The use of a single rat strain and a specific exposure window may not fully capture interspecies, interstrain, or developmental stage variability. Additionally, while the in vitro findings support the in vivo observations, the translation to human neurodevelopmental risk remains to be established.

Transferability to other neurotoxicant models or to clinical contexts should be approached cautiously; further studies are needed to validate whether similar p53-mediated ferroptotic mechanisms operate in response to diverse environmental insults or in human populations.

Research Support Resources

Researchers aiming to reproduce or extend these findings can incorporate chemical modulators for pathway dissection. Pifithrin-α (PFTα) (SKU A4206) from APExBIO is a well-characterized p53 inhibitor suitable for in vitro and in vivo studies of p53-dependent apoptosis inhibition and ferroptosis. Its established ability to block p53-responsive gene activation allows precise interrogation of the p53 pathway in models of neurotoxicity, cell cycle arrest, and protection from gamma irradiation. For detailed mechanistic workflows and further protocol guidance, the referenced internal and external articles provide a strong foundation for methodological planning.